Related Experiment Video
Updated: Jul 30, 2026
04:04
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
[Extended and combined operations for lung cancer]
Vestnik Khirurgii Imeni I. I. Grekova
|March 21, 2002
Summary
Advanced surgical treatment for late-stage lung cancer, specifically TNM stage IIIA, shows promising long-term survival rates. Over 21% of patients survived more than five years, validating the effectiveness of surgical intervention.
Area of Science:
- Oncology
- Thoracic Surgery
Context:
- Retrospective analysis of 1720 patients with advanced lung cancer (TNM staging).
- Focus on patients with later stages of lung cancer undergoing surgical treatment.
- Data collected from long-term clinical operations.
Purpose:
- To evaluate the efficacy of extended and combined operative interventions for advanced lung cancer.
- To analyze postoperative treatment and long-term survival outcomes.
- To determine the expediency of surgical treatment for TNM stage IIIA lung cancer.
Summary:
- 1720 patients with advanced lung cancer (TNM staging) were analyzed.
- Specifics of extended/combined surgeries and postoperative care were detailed.
- 5-year survival rates of 26% (IIIA) and 21.5% (IIIA) were observed post-discharge.
Impact:
- Demonstrates significant long-term survival benefits for surgically treated advanced lung cancer patients.
- Highlights the value of aggressive surgical approaches in improving patient outcomes.
- Provides evidence supporting surgical intervention as a viable treatment option for stage IIIA lung cancer.
